BLISSGVS — Bliss GVS Pharma Balance Sheet
0.000.00%
Last trade - 00:00
- IN₹12.84bn
- IN₹12.46bn
- IN₹7.52bn
- 82
- 34
- 84
- 80
2019 March 31st | R2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 1,055 | 501 | 778 | 1,459 | 726 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 4,612 | 5,531 | 4,700 | 4,069 | 4,281 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 6,936 | 7,697 | 7,652 | 7,760 | 6,974 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 1,815 | 2,326 | 2,278 | 2,948 | 3,729 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 9,049 | 10,272 | 10,768 | 11,087 | 11,569 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 2,070 | 2,305 | 2,036 | 2,331 | 1,933 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 2,589 | 2,916 | 2,685 | 2,900 | 2,730 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 6,460 | 7,356 | 8,083 | 8,187 | 8,839 |
Total Liabilities & Shareholders' Equity | 9,049 | 10,272 | 10,768 | 11,087 | 11,569 |
Total Common Shares Outstanding |